| Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
|---|
| 11/07/2013 | US20130295097 Human Antibodies to Fel d1 and Methods of Use Thereof |
| 11/07/2013 | US20130295093 Fusion constructs containing active sections of tnf ligands |
| 11/07/2013 | US20130295092 Method for the Treatment of Neurodegenerative Diseases |
| 11/07/2013 | US20130295091 Combination therapy including tumor associated antigen binding antibodies |
| 11/07/2013 | US20130295089 Method of promoting bone growth by an anti-actriia antibody |
| 11/07/2013 | US20130295088 Methods of treating inflammatory pain |
| 11/07/2013 | US20130295087 Methods of treating chronic pain |
| 11/07/2013 | US20130295082 Antibody formulations and methods |
| 11/07/2013 | US20130295050 Anti-igf-i receptor antibodies, dnas, vectors, host cells and genetic constructs |
| 11/07/2013 | US20130295045 Medicament comprising recombinant antibody against chemokine receptor ccr4 |
| 11/07/2013 | US20130295043 Vaccination in elderly patients |
| 11/07/2013 | US20130295021 Human anti-tau antibodies |
| 11/07/2013 | US20130295007 Anti-pmel17 antibodies and immunoconjugates |
| 11/07/2013 | US20130295005 Combination Therapy With Anti-CD74 Antibodies Provides Enhanced Toxicity to Malignancies, Autoimmune Disease and Other Diseases |
| 11/07/2013 | US20130295004 Il-1 binding proteins |
| 11/07/2013 | CA2871985A1 Anti-il-23p19 antibodies |
| 11/06/2013 | EP2660604A2 Immunogenic Streptococcus proteins |
| 11/06/2013 | EP2660335A2 Highly conserved genes and their use to generate species-specific, genus-specific, family-specific, group-specific and universal nucleic acid probes and amplification primers to rapidly detect and identify algal, archaeal, bacterial, fungal and parasitical microorgamisms from clinical specimens for diagnosis |
| 11/06/2013 | EP2659912A2 Conjugate purification |
| 11/06/2013 | EP2659910A1 Method for suppressing receptor tyrosine kinase-mediated prosurvival signaling in cancer cells |
| 11/06/2013 | EP2659908A1 Compositions |
| 11/06/2013 | EP2659907A1 Compositions |
| 11/06/2013 | EP2659906A1 Compositions |
| 11/06/2013 | EP2659893A2 T cell regulation |
| 11/06/2013 | EP2658974A1 Immunostimulatory oligodeoxynucleotides |
| 11/06/2013 | EP2658873A2 A cross-linking polypeptide that induces apoptosis |
| 11/06/2013 | EP2658866A1 Salmonid alphavirus protein e2 |
| 11/06/2013 | EP2658865A2 IDENTIFICATION OF A NOVEL HUMAN POLYOMAVIRUS (IPPyV) AND APPLICATIONS |
| 11/06/2013 | EP2658575A1 Pharmaceutical formulation comprising a biopharmaceutical drug |
| 11/06/2013 | EP2658574A1 Polymalic acid-based nanobiopolymer compositions and methods for treating cancer |
| 11/06/2013 | EP2658573A2 Expression systems |
| 11/06/2013 | EP2658572A1 Fluorocarbon-linked peptide formulation |
| 11/06/2013 | EP2658571A1 Inactivated poliovaccine |
| 11/06/2013 | EP2658570A1 Bovine viral diarrhea virus type 1b vaccine compositions and methods |
| 11/06/2013 | EP2658569A1 Combination of vaccination and inhibition of mhc class restricted antigen presentation |
| 11/06/2013 | EP2658568A1 Canine babesiosis vaccine antigen |
| 11/06/2013 | EP2359853B1 Pharmaceutical compositions and methods useful for modulating angiogenesis |
| 11/06/2013 | EP2139497B1 Methods for treating nervous system injury and disease |
| 11/06/2013 | CN103384827A Biomarkers for predicting the efficacy of an immunotherapy against cancer |
| 11/06/2013 | CN103384532A Vaccine for inducing an improved immune reaction |
| 11/06/2013 | CN103384531A Modified influenza hemagglutinin proteins and uses thereof |
| 11/06/2013 | CN103384530A Breast cancer therapeutics |
| 11/06/2013 | CN103384515A Lipids suitable for liposomal delivery of protein-coding RNA |
| 11/06/2013 | CN103382480A Asia 1 type foot and mouth disease virus antigen and preparation and application thereof |
| 11/06/2013 | CN103382460A Strain of Marek's disease virus vaccine strain, and separation and identification and application thereof |
| 11/06/2013 | CN103382223A Multi-functional antibody polypeptide aiming at epidermal growth factor receptor (EGFR) cryptic epitope and T cell antigen |
| 11/06/2013 | CN103382222A Alpha-4-beta-7 heterodimer specific antagonist antibody |
| 11/06/2013 | CN103382220A Cell factor FAM19A4 with anti-infection and antineoplastic activity and application thereof |
| 11/06/2013 | CN103381274A Genetic products differentially expressed in tumors and the use thereof |
| 11/06/2013 | CN102925486B Porcine circovirus type 2 subunit vaccine, and preparation method and application thereof |
| 11/06/2013 | CN102772797B Genetic engineering polypeptide vaccine for 4 subtypes of O-type foot and mouth disease virus and its application |
| 11/06/2013 | CN102703369B Recombinant bifidobacterium for preparing EV (Enterovirus) 71 vaccine as well as preparation method and application of recombinant bifidobacterium |
| 11/06/2013 | CN102659922B Peptide Derived From Hepatitis C Virus |
| 11/06/2013 | CN102559612B Recombinant newcastle disease virus LaSota vaccine strain for expressing Nipah virus encephalitis G-protein |
| 11/06/2013 | CN102552906B Productive technology of intravenous injection human immunoglobulin |
| 11/06/2013 | CN102223887B Method for treating parkinson's disease using filamentous phage |
| 11/06/2013 | CN102206275B Anti-tetanotoxin monoclonal neutral antibody, and composition and application thereof |
| 11/06/2013 | CN102186498B Vaccine for treatment/prevention of scuticociliatosis in fish |
| 11/06/2013 | CN102078605B Method for preparing Vero cell influenza virus vaccine |
| 11/06/2013 | CN101954080B Compound-molecule adjuvant for swine foot-and-mouth vaccine and preparation method thereof |
| 11/06/2013 | CN101918555B Humanized anti-alpha9 integrin antibodies and the uses thereof |
| 11/06/2013 | CN101878038B Engineered pertactin variants for vaccine use |
| 11/06/2013 | CN101855241B Monoclonal antibodies against ANGPTL3 |
| 11/06/2013 | CN101835892B CDCA1 peptide and pharmaceutical agent comprising the same |
| 11/06/2013 | CN101679523B Novel fully human anti-vap-1 monoclonal antibodies |
| 11/06/2013 | CN101657467B Human cytomegalovirus neutralising antibodies and use thereof |
| 11/06/2013 | CN101632833B Prostatic cancer related gene and application thereof |
| 11/06/2013 | CN101628111B Taci-immunoglobulin fusion proteins |
| 11/06/2013 | CN101622275B Method of providing disease-specific binding molecules and targets |
| 11/06/2013 | CN101611320B Method for assaying antibodies in body fluids by immune reaction with glycoprotein 2 (gp2) from zymogenic granules of the pancreas for the diagnosis of inflammatory intestinal diseases and chronic pan |
| 11/06/2013 | CN101595127B Protein composition for inducing an immune response in a vertebrate comprising a plurality of protein variants covering the heterogeneity of a single antigen, AMA1 |
| 11/06/2013 | CN101506238B Methods and compositions with enhanced therapeutic activity |
| 11/06/2013 | CN101484471B Anti-NKG2A antibodies and uses thereof |
| 11/06/2013 | CN101472604B Viable non-toxic gram negative bacteria |
| 11/06/2013 | CN101466736B Therapy targeting cathepsin S |
| 11/06/2013 | CN101302515B Human antibodies that bind human TNF(alpha) |
| 11/06/2013 | CN101248084B Tuberculosis vaccines comprising antigens expressed during the latent infection phase |
| 11/06/2013 | CN101189334B 抗cd14抗体融合蛋白质 Anti-cd14 antibody fusion proteins |
| 11/06/2013 | CN101073667B Enhancer for antibody to lymphocytic tumors |
| 11/05/2013 | US8575317 Anti-NR10 antibody and use thereof |
| 11/05/2013 | US8575315 Immunizing compositions and methods of use |
| 11/05/2013 | US8575110 Peptidic nanoparticles as drug delivery and antigen display systems |
| 11/05/2013 | US8574901 Cryoconserved mature dendritic cells |
| 11/05/2013 | US8574828 Controlled platelet activation to monitor therapy of ADP antagonists |
| 11/05/2013 | US8574599 Methods and products for inducing mucosal immunity |
| 11/05/2013 | US8574598 Agents for the prevention of leishmaniasis |
| 11/05/2013 | US8574597 Immunogenic compositions for the prevention and treatment of meningococcal disease |
| 11/05/2013 | US8574596 Pertussis antigens and use thereof in vaccination |
| 11/05/2013 | US8574595 Virus purification using ultrafiltration |
| 11/05/2013 | US8574594 Generation of replication competent viruses for therapeutic use |
| 11/05/2013 | US8574593 Influenza hemagglutinin and neuraminidase variants |
| 11/05/2013 | US8574592 Modified influenza virus for monitoring and improving vaccine efficiency |
| 11/05/2013 | US8574591 Multi plasmid system for the production of influenza virus |
| 11/05/2013 | US8574590 Lipoparticles comprising proteins, methods of making, and using the same |
| 11/05/2013 | US8574589 Antigen purification process for pertactin antigen |
| 11/05/2013 | US8574588 Fusion proteins comprising flagellin and dengue viral envelope proteins |
| 11/05/2013 | US8574586 KDR peptides and vaccines comprising the same |
| 11/05/2013 | US8574585 KDR peptides and vaccines comprising the same |
| 11/05/2013 | US8574584 EphA2 T cell epitopes and uses therefor |
| 11/05/2013 | US8574583 AAV capsid library and AAV capsid proteins |